MAIA Historical Financial Ratios
| MAIA Stock | USD 1.63 0.02 1.21% |
MAIA Biotechnology is lately reporting on over 80 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate MAIA Biotechnology financial condition quickly.
MAIA |
About MAIA Financial Ratios Analysis
MAIA BiotechnologyFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate MAIA Biotechnology investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on MAIA financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across MAIA Biotechnology history.
MAIA Biotechnology Financial Ratios Chart
Add Fundamental
Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Income Quality
An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Most ratios from MAIA Biotechnology's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into MAIA Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MAIA Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade MAIA Stock refer to our How to Trade MAIA Stock guide.At present, MAIA Biotechnology's PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 0.26, whereas Free Cash Flow Yield is forecasted to decline to (0.38).
MAIA Biotechnology fundamentals Correlations
Click cells to compare fundamentals
MAIA Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
MAIA Biotechnology fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | (14.22) | 5.17 | 3.83 | 32.49 | 12.09 | 12.7 | |
| Book Value Per Share | (0.15) | 0.86 | 0.92 | 0.036 | 0.16 | 0.26 | |
| Operating Cash Flow Per Share | (0.17) | (0.39) | (1.26) | (0.99) | (0.71) | (0.74) | |
| Pb Ratio | (14.22) | 5.17 | 3.83 | 32.49 | 12.09 | 12.7 | |
| Free Cash Flow Per Share | (0.17) | (0.39) | (1.26) | (0.99) | (0.71) | (0.74) | |
| Roic | 7.3 | (0.9) | (1.85) | (7.67) | (2.68) | (2.81) | |
| Net Income Per Share | (0.63) | (1.25) | (1.7) | (1.49) | (1.05) | (1.1) | |
| Cash Per Share | 0.0624 | 0.99 | 1.18 | 0.54 | 0.43 | 0.45 | |
| Pocfratio | (25.72) | (11.51) | (2.79) | (1.19) | (2.8) | (2.94) | |
| Pfcf Ratio | (25.72) | (11.51) | (2.79) | (1.19) | (2.8) | (2.94) | |
| Income Quality | 0.26 | 0.33 | 0.74 | 0.66 | 0.68 | 0.38 | |
| Roe | 2.0 | (1.45) | (1.86) | (41.41) | (6.4) | (6.08) | |
| Ev To Operating Cash Flow | (25.61) | (8.94) | (1.85) | (0.64) | (2.19) | (2.3) | |
| Pe Ratio | (7.11) | (3.57) | (2.06) | (0.78) | (1.89) | (1.98) | |
| Return On Tangible Assets | (8.93) | (1.17) | (1.31) | (2.61) | (2.29) | (2.4) | |
| Ev To Free Cash Flow | (25.61) | (8.94) | (1.85) | (0.64) | (2.19) | (2.3) | |
| Current Ratio | 0.44 | 4.97 | 3.61 | 1.53 | 2.65 | 3.27 | |
| Tangible Book Value Per Share | (0.15) | 0.86 | 0.92 | 0.036 | 0.16 | 0.26 | |
| Shareholders Equity Per Share | (0.31) | 0.86 | 0.92 | 0.036 | 0.16 | 0.22 | |
| Graham Net Net | (0.16) | 0.79 | 0.83 | 0.0128 | 0.14 | 0.23 | |
| Price Earnings Ratio | (7.11) | (3.57) | (2.06) | (0.78) | (1.89) | (1.98) | |
| Price Book Value Ratio | (14.22) | 5.17 | 3.83 | 32.49 | 12.09 | 12.7 | |
| Price To Operating Cash Flows Ratio | (25.72) | (11.51) | (2.79) | (1.19) | (2.8) | (2.94) | |
| Price To Free Cash Flows Ratio | (25.72) | (11.51) | (2.79) | (1.19) | (2.8) | (2.94) | |
| Company Equity Multiplier | (0.22) | 1.23 | 1.41 | 15.85 | 2.79 | 1.47 | |
| Return On Capital Employed | 7.36 | (0.85) | (1.85) | (7.67) | (2.68) | (2.81) | |
| Quick Ratio | 0.44 | 4.99 | 3.61 | 1.53 | 2.65 | 3.28 | |
| Cash Ratio | 0.39 | 4.93 | 3.35 | 1.45 | 2.51 | 3.15 | |
| Price To Book Ratio | (14.22) | 5.17 | 3.83 | 32.49 | 12.09 | 12.7 | |
| Price Cash Flow Ratio | (25.72) | (11.51) | (2.79) | (1.19) | (2.8) | (2.94) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MAIA Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For information on how to trade MAIA Stock refer to our How to Trade MAIA Stock guide.You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MAIA Biotechnology. If investors know MAIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MAIA Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MAIA Biotechnology is measured differently than its book value, which is the value of MAIA that is recorded on the company's balance sheet. Investors also form their own opinion of MAIA Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is MAIA Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MAIA Biotechnology's market value can be influenced by many factors that don't directly affect MAIA Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MAIA Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if MAIA Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MAIA Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.